E. Nisoli et al., DIFFERENTIAL RELEVANCE OF BETA-ADRENOCEPTOR SUBTYPES IN MODULATING THE RAT BROWN ADIPOCYTES FUNCTION, Archives internationales de pharmacodynamie et de therapie, 329(3), 1995, pp. 436-453
The potencies and intrinsic activities on cyclic AMP accumulation and
lipolysis of various selective beta(3)-adrenoceptor agonists were stud
ied in brown adipocytes and compared to those of the nonselective, (-)
-isoprenaline, and conventional beta(1)-(dobutamine) and beta(2)-adren
oceptor (salbutamol) agonists. (-)-Isoprenaline, dobutamine and salbut
amol were more potent stimulants of lipolysis than of cyclic AMP accum
ulation, while the selective beta(3)-adrenoceptor agonists had similar
potencies for these two functions. Apparent pA(2) values of the selec
tive beta(1)-(CGP20712A) and beta(2)-adrenoceptor (ICI118551) antagoni
sts for inhibition of adenylyl cyclase stimulation by (-)-isoprenaline
and the beta(3)-adrenoceptor agonists, BRL37344, SR58611A, and ICI215
001, indicated that (-)-isoprenaline can stimulate the enzyme through
a relevant beta(1)-adrenergic component, while the other drugs activat
e the enzyme mainly by acting on the beta(3)-adrenoceptors. On the con
trary, antagonism of the lipolysis yielded apparent pA(2) values for C
GP20712A and ICI118551, suggesting that (-)-isoprenaline, like all the
beta(3)-adrenoceptor agonists, stimulated the brown adipose tissue li
pid metabolism mainly through an action on beta(3)-adrenoceptors.